DnB Asset Management
FMI

DnB Asset Management’s Foundation Medicine, Inc. FMI Stock Holding History

DnB Asset Management’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,800
Closed -$232K – 544
2016
Q1 		$232K Hold
12,800
– – ﹤0.01% 520
2015
Q4 		$269K Buy
+12,800
New +$247K 0.01% 449

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DnB Asset Management's FMI Position: Q2 2016 in Review

DnB Asset Management sold out of Foundation Medicine, Inc. (FMI) in Q2 2016, closing a stake of 12,800 shares — an estimated $232K sold.

DnB Asset Management first reported a position in FMI in Q4 2015 and held it in 2 quarters. The position peaked at $269K in Q4 2015. 92 funds tracked by Wall St. Rank hold FMI as of Q2 2016.

  • DnB Asset Management reported no remaining Foundation Medicine, Inc. position as of Q2 2016 after selling out during the quarter.
  • DnB Asset Management sold 12,800 Foundation Medicine, Inc. shares in Q2 2016, an estimated $232K.
  • DnB Asset Management first reported a position in Foundation Medicine, Inc. in Q4 2015 and held it in 2 quarters.
  • DnB Asset Management's Foundation Medicine, Inc. position peaked at $269K in Q4 2015.
  • 92 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2016.

Based on DnB Asset Management's 13F filing for Q2 2016, filed 8 Jul 2016.